植恩生物技术股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
26
NMPA:26
Drug Approvals
Pramipexole Dihydrochloride Tablets
- Product Name
- 盐酸普拉克索片
- Approval Number
- 国药准字H20254233
- Approval Date
- May 20, 2025
NMPA
Pramipexole Dihydrochloride Tablets
- Product Name
- 盐酸普拉克索片
- Approval Number
- 国药准字H20254232
- Approval Date
- May 20, 2025
NMPA
Ropinirole Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸罗匹尼罗缓释片
- Approval Number
- 国药准字H20253817
- Approval Date
- Apr 8, 2025
NMPA
Pramipexole Dihydrochloride Sustained-release Tablets
- Product Name
- 盐酸普拉克索缓释片
- Approval Number
- 国药准字H20253686
- Approval Date
- Mar 25, 2025
NMPA
Pramipexole Dihydrochloride Sustained-release Tablets
- Product Name
- 盐酸普拉克索缓释片
- Approval Number
- 国药准字H20253687
- Approval Date
- Mar 25, 2025
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20253123
- Approval Date
- Jan 8, 2025
NMPA
Flupentixol and Melitracen Tablets
- Product Name
- 氟哌噻吨美利曲辛片
- Approval Number
- 国药准字H20249160
- Approval Date
- Oct 22, 2024
NMPA
Sildenafil Citrate Tablets
- Product Name
- 枸橼酸西地那非片
- Approval Number
- 国药准字H20244696
- Approval Date
- Aug 20, 2024
NMPA
Sildenafil Citrate Tablets
- Product Name
- 枸橼酸西地那非片
- Approval Number
- 国药准字H20244695
- Approval Date
- Aug 20, 2024
NMPA
Sildenafil Citrate Tablets
- Product Name
- 枸橼酸西地那非片
- Approval Number
- 国药准字H20244697
- Approval Date
- Aug 20, 2024
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found